ClinicalTrials.Veeva

Menu

A Comparison of Farabloc Fabric With Placebo on Alleviation Hot Flash in Menopausal Women

University of British Columbia logo

University of British Columbia

Status

Unknown

Conditions

Menopause

Treatments

Device: Nylon Fabric
Device: Farabloc

Study type

Interventional

Funder types

Other

Identifiers

NCT02006238
H13-03052

Details and patient eligibility

About

This is a prospective, randomized, double-blind, crossover study. The purpose of this study is to determine whether Farabloc fabric is effective in alleviation of hot flash symptoms in menopausal women. This study will require all prospective participants to fill out a week of Hot Flash Diary to determine eligibility before beginning the study. All prospective participants will be assessed for hot flash frequency, hot flash distress and hot flash severity according to their perception in the Hot Flash Diary during the experimental period.

Full description

Fifty menopausal volunteers will be randomly assigned to two groups, one receiving Farabloc fabric containing Farabloc (experimental), and the other a similar-appearing fabric made of Nylon (placebo).

All eligible participants will be selected by the initial interview. The following information will be collected during interview process.

  • Address
  • Medical history
  • Concomitant medication
  • Allergies

Participants will be asked the following:

  1. On a scale from 1 to 10, how much are you bothered by your hot flashes?
  2. Do these hot flashes wake you up at night? Around how many times do they occur at night?
  3. What are you expectations about this study?

A Menopause Rating Scale questionnaire will be completed by the potential participant to assess symptoms Eligible patients from each group will initially undergo a 7 day washout period before intervention in order to eliminate any effects of hormone replacement therapies (HRT) or herbal supplements that subjects may be using prior to participation in the study. Subjects will be randomized to receive a Farabloc fabric or placebo fabric for one week. After this, the two groups will undergo a second 7 day washout period before crossing over to the other fabric. Once crossed over, participants will use the allocated fabrics for another week.

Participants will be asked not to take their usual HRT or herbal supplements for the entire experimental duration in this study in order to produce impartial, precise and reliable results.

The manufacturer will assign codes for placebo fabric or experimental Farabloc. The randomization code will be broken at the completion of the study for data analysis.

Enrollment

50 estimated patients

Sex

Female

Ages

45 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Women with 12 months amenorrhea
  • Experiencing more than 2 nocturnal hot flashes nightly.

Exclusion criteria

  • Other medical conditions associated with night sweats
  • Currently on medication associated with night sweats
  • Less than 2 nocturnal hot flashes per night
  • Allergies to metals
  • Abnormal mental status
  • MRS scale rating of mild or above
  • Currently on hormone replacement therapy or herbal supplements and cannot safety discontinue these for the duration of the study.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

50 participants in 2 patient groups, including a placebo group

Farabloc
Experimental group
Description:
The participants will sleep on Farabloc fabric nightly for a week.
Treatment:
Device: Nylon Fabric
Device: Farabloc
Nylon Fabric
Placebo Comparator group
Description:
The participants will sleep on Nylon fabric nightly for week.
Treatment:
Device: Nylon Fabric
Device: Farabloc

Trial contacts and locations

1

Loading...

Central trial contact

York N Hsiang, MB FRCSC; Rollin Y Yu

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems